Boulder Biotech Sold Again: Illumina Strikes $425M Deal for Proteomics ...

Standard BioTools stock soars after selling SomaLogic to Illumina for $425M

Boulder biotech sold again: Illumina strikes $425M deal for proteomics ...

Illumina to buy SomaLogic for up to $425M

Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.

Illumina to buy SomaLogic in deal worth up to $425M

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene sequencing products.

Standard BioTools jumps on sale of SomaLogic to Illumina

Illumina to buy SomaLogic in deal worth up to $425M – RamaOnHealthcare

Illumina expects that adding SomaLogic will aid its “multiomics” business strategy and strengthen the value of its gene sequencing products.Illumina on Monday said it agreed to acquire SomaLogic and other assets from Standard BioTools for $350 million in cash to expand in the proteomics market.The deal includes additional near-term payments of up to $75 million [...]